1. Cavilon™ Advanced Skin Protectant
3M Health Care
A woman clinician wearing a stethoscope.
View Video

Finally… the power to end Incontinence-Associated Dermatitis (IAD).

Incontinence-Associated Dermatitis has met its match.

3M™ Cavilon™ Advanced Skin Protectant has been shown to significantly improve severe cases of IAD - even in the presence of continued incontinence. Cavilon advanced skin protectant creates a highly durable, ultra-thin, transparent barrier and doesn't require removal, protecting patient's skin like never before.

A hand wearing a purple latex glove holding a 3M™ Cavilon™ Advanced Skin Protectant applicator.
Revolutionising the science of skin protection.

What makes it so revolutionary?

  • Reduces patient pain1

    Creates a protective environment that supports healing and helps reduce pain associated with IAD1

  • Long-lasting

    Application only needed two times per week

  • Hard-working

    Attaches to wet, weepy damaged skin surfaces (i.e. superficial partial thickness skin loss)1

  • No need to remove

    Allows easy, gentle cleansing with no removal required

Designed to make a difference.

  • For your patients and residents

    For your patients and residents:

    • Prevents skin injury and maintains skin integrity1
    • Reduces the pain associated with managing IAD1
    • Creates an environment for healing moderate to severe IAD3
    • Prevents, stops and reverses IAD
  • Clinicians standing in a hallway of a busy hospital.

    For your facility:

    • Leads to improved patient and resident outcomes1
    • Offers a cost effective solution for the management and prevention of IAD
  • Nurse using Cavilon Advanced Skin Protectant

    For you:

    • Reduces overall time spent on the prevention and management of IAD and other types of skin damage
    • Supports infection-control initiatives
Purple to blue gradient background.
Revolutionising the science of skin protection.

3M chemists partnered with leading clinicians and IAD experts to develop Cavilon Advanced Skin Protectant. The results of clinical studies in two nursing care facilities speak for themselves.

  • 96% the median percent improvement in IAD severity score copy with an icon of a man.
  • 100% of patients reporting pain on Day 1 (n=9) saw a reduction in pain copy on a yellow background.

In a case series of incontinent patients (n=16), the median percent improvement in IAD severity score was 96%, and 100% of incontinent patients who reported pain on Day 1 saw a reduction in pain with the use of Cavilon advanced skin protectant.4

Purple to blue gradient background.
Revolutionising experiences and outcomes.
  • A side by side comparison of a patient on day one and day four.

    Cavilon Advanced Skin Protectant - the difference is clear.

    Whilst Cavilon advanced skin protectant is invisible, the benefits of improved protection are clearly visible.

    Clinical evaluation of a New Advanced Skin Protectant for the management of incontinence-associated dermatitis Mary R. Brennan, Catherine T. Milne, Bruce P. Ekholm, Fran Kleinsteuber.

    Poster presented at CAWC conference 2016

A close-up image of a clinician holding a 3M™ Cavilon™ Advanced Skin Protectant applicator.
Experience the unparalleled power for yourself.
REQUEST AN IN-PERSON DEMO.
  • Application Guide (PDF, 2.46 MB)

    Discover how protecting at-risk patients from IAD and its associated complications is easier than ever before.

  • IAD is a challenge in acute and loing-term care settings. Learn more about the importance of maintaining the skin integrity of patients at risk of IAD

References

1. Brennan MR, Milne CT, Agrell-Kann M, Ekholm BP . Clinical evaluation of a barrier film for the management of incontinence associated dermatitis (IAD) in an open label, non-randomized, prospective study. Accepted for publication in Journal of Wound, Ostomy, and Continence Nursing (JWOCN).
2. 3M data on file. EM-05-013924.
3. Been R, Bernatchez SF, Conrad-Vlasak D, Asmus R, Eckholm B, P arks PJ. In vivo methods to evaluate a new skin protectant for loss of skin integrity. Accepted for publication in Wound Repair & Regeneration. DOI: 10.1111/wrr.12455 (http://onlinelibrary.wiley.com/doi/10.1111/wrr.12455/abstract)(in an animal model).
4. Brennan MR, Milne CT, Agrell-Kann M, Ekholm BP. Clinical evaluation of a barrier film for the management of incontinence associated dermatitis (IAD) in an open label, non-randomized, prospective study. Accepted for publication in Journal of Wound, Ostomy, and Continence Nursing (JWOCN). (n=9).

Follow Us
The brands listed above are trademarks of 3M.
Change Location
United Kingdom - English